STOK logo

Stoke Therapeutics, Inc. (STOK) Return On Equity

Annual ROE:

-45.80%+15.00%(+24.67%)
December 31, 2024

Summary

  • As of today, STOK annual return on equity is -45.80%, with the most recent change of +15.00% (+24.67%) on December 31, 2024.
  • During the last 3 years, STOK annual ROE has fallen by -11.74% (-34.47%).
  • STOK annual ROE is now -110.65% below its all-time high of 430.19%, reached on December 31, 2017.

Performance

STOK ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKprofitability metrics

Quarterly ROE:

13.95%-4.94%(-26.15%)
September 30, 2025

Summary

  • As of today, STOK quarterly return on equity is 13.95%, with the most recent change of -4.94% (-26.15%) on September 30, 2025.
  • Over the past year, STOK quarterly ROE has increased by +69.59% (+125.07%).
  • STOK quarterly ROE is now -33.73% below its all-time high of 21.05%, reached on March 31, 2025.

Performance

STOK Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

STOK ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+24.7%+125.1%
3Y3 Years-34.5%+131.4%
5Y5 Years-133.4%+162.3%

STOK ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-34.5%+24.7%-33.7%+122.5%
5Y5-Year-133.4%+24.7%-33.7%+122.5%
All-TimeAll-Time-110.7%+24.7%-33.7%+122.5%

STOK ROE History

DateAnnualQuarterly
Sep 2025
-
13.95%(-26.2%)
Jun 2025
-
18.89%(-10.3%)
Mar 2025
-
21.05%(+147.5%)
Dec 2024
-45.80%(+24.7%)
-44.32%(+20.3%)
Sep 2024
-
-55.64%(+2.7%)
Jun 2024
-
-57.17%(+7.6%)
Mar 2024
-
-61.88%(-8.9%)
Dec 2023
-60.80%(-21.1%)
-56.81%(-6.1%)
Sep 2023
-
-53.52%(-3.7%)
Jun 2023
-
-51.59%(-11.3%)
Mar 2023
-
-46.37%(+1.7%)
Dec 2022
-50.20%
-47.18%(-6.2%)
Sep 2022
-
-44.43%(-8.3%)
Jun 2022
-
-41.01%(-7.1%)
DateAnnualQuarterly
Mar 2022
-
-38.30%(-13.3%)
Dec 2021
-34.06%(-66.4%)
-33.81%(-10.8%)
Sep 2021
-
-30.52%(-10.2%)
Jun 2021
-
-27.70%(-11.6%)
Mar 2021
-
-24.81%(-6.4%)
Dec 2020
-20.47%(-4.3%)
-23.31%(-4.1%)
Sep 2020
-
-22.39%(-17.0%)
Jun 2020
-
-19.13%(-3.1%)
Mar 2020
-
-18.56%(-14.7%)
Dec 2019
-19.62%(+18.7%)
-16.18%(-28.7%)
Sep 2019
-
-12.57%(+11.7%)
Jun 2019
-
-14.23%(+11.0%)
Mar 2019
-
-15.98%(-34.1%)
Dec 2018
-24.13%(-105.6%)
-11.92%
Dec 2017
430.19%
-

FAQ

  • What is Stoke Therapeutics, Inc. annual return on equity?
  • What is the all-time high annual ROE for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. annual ROE year-on-year change?
  • What is Stoke Therapeutics, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. quarterly ROE year-on-year change?

What is Stoke Therapeutics, Inc. annual return on equity?

The current annual ROE of STOK is -45.80%

What is the all-time high annual ROE for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high annual return on equity is 430.19%

What is Stoke Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, STOK annual return on equity has changed by +15.00% (+24.67%)

What is Stoke Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of STOK is 13.95%

What is the all-time high quarterly ROE for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high quarterly return on equity is 21.05%

What is Stoke Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, STOK quarterly return on equity has changed by +69.59% (+125.07%)
On this page